- Gastroenterology Education and CPD for trainees and specialists - https://www.gastrotraining.com -

AASLD: HCV Testing by Birth Cohort Cost-Effective (CME/CE)

SAN FRANCISCO (MedPage Today) — Birth-cohort screening for hepatitis C virus infection proved highly cost-effective, even when universal treatment with direct-acting antiviral therapy was factored in, according to a study reported here.


Article printed from Gastroenterology Education and CPD for trainees and specialists: https://www.gastrotraining.com